NM_004308.5:c.-170A>G
Variant names:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4BP6_Very_StrongBA1
The NM_004308.5(ARHGAP1):c.-170A>G variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.6 in 393,766 control chromosomes in the GnomAD database, including 77,556 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.54 ( 25383 hom., cov: 32)
Exomes 𝑓: 0.64 ( 52173 hom. )
Consequence
ARHGAP1
NM_004308.5 upstream_gene
NM_004308.5 upstream_gene
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.233
Genes affected
ARHGAP1 (HGNC:673): (Rho GTPase activating protein 1) This gene encodes a member of a large family of proteins that activate Rho-type guanosine triphosphate (GTP) metabolizing enzymes. The encoded protein contains a SRC homology 3 domain and interacts with Bcl-2-associated protein family members. [provided by RefSeq, Aug 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.18).
BP6
Variant 11-46700671-T-C is Benign according to our data. Variant chr11-46700671-T-C is described in ClinVar as [Benign]. Clinvar id is 1276936.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.696 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGAP1 | NM_004308.5 | c.-170A>G | upstream_gene_variant | ENST00000311956.9 | NP_004299.1 | |||
ARHGAP1 | XM_047426933.1 | c.-129A>G | upstream_gene_variant | XP_047282889.1 | ||||
ARHGAP1 | XM_024448520.2 | c.-170A>G | upstream_gene_variant | XP_024304288.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.536 AC: 81400AN: 151854Hom.: 25376 Cov.: 32
GnomAD3 genomes
AF:
AC:
81400
AN:
151854
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.640 AC: 154704AN: 241794Hom.: 52173 Cov.: 0 AF XY: 0.643 AC XY: 82355AN XY: 128040
GnomAD4 exome
AF:
AC:
154704
AN:
241794
Hom.:
Cov.:
0
AF XY:
AC XY:
82355
AN XY:
128040
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.536 AC: 81411AN: 151972Hom.: 25383 Cov.: 32 AF XY: 0.535 AC XY: 39733AN XY: 74280
GnomAD4 genome
AF:
AC:
81411
AN:
151972
Hom.:
Cov.:
32
AF XY:
AC XY:
39733
AN XY:
74280
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1855
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
May 16, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at